相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Multiple system degeneration with basophilic inclusions in Japanese ALS patients with FUS mutation
Takahisa Tateishi et al.
ACTA NEUROPATHOLOGICA (2010)
Methionine sulfoximine, an inhibitor of glutamine synthetase, lowers brain glutamine and glutamate in a mouse model of ALS
Farhad Ghoddoussi et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2010)
Lead exposure stimulates VEGF expression in the spinal cord and extends survival in a mouse model of ALS
Ana G. Barbeito et al.
NEUROBIOLOGY OF DISEASE (2010)
Dietary Supplementation with S-Adenosyl Methionine Delays the Onset of Motor Neuron Pathology in a Murine Model of Amyotrophic Lateral Sclerosis
James Suchy et al.
NEUROMOLECULAR MEDICINE (2010)
Caloric Restriction Shortens Lifespan through an Increase in Lipid Peroxidation, Inflammation and Apoptosis in the G93A Mouse, an Animal Model of ALS
Barkha P. Patel et al.
PLOS ONE (2010)
Treatment with lithium carbonate does not improve disease progression in two different strains of SOD1 mutant mice
Chiara Pizzasegola et al.
AMYOTROPHIC LATERAL SCLEROSIS (2009)
Combined riluzole and sodium phenylbutyrate therapy in transgenic amyotrophic lateral sclerosis mice
Steven J. Del Signore et al.
AMYOTROPHIC LATERAL SCLEROSIS (2009)
Motor neuronal protection by L-arginine prolongs survival of mutant SOD1 (G93A) ALS mice
Junghee Lee et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2009)
The Chinese Prescription Wen-Pi-Tang Extract Delays Disease Onset in Amyotrophic Lateral Sclerosis Model Mice While Attenuating the Activation of Glial Cells in the Spinal Cord
Michiko Sekiya et al.
BIOLOGICAL & PHARMACEUTICAL BULLETIN (2009)
Intra-bone marrow-bone marrow transplantation slows disease progression and prolongs survival in G93A mutant SOD1 transgenic mice, an animal model mouse for amyotrophic lateral sclerosis
Shizuo Ohnishi et al.
BRAIN RESEARCH (2009)
Sensory involvement in the SOD1-G93A mouse model of amyotrophic lateral sclerosis
Yan-Su Guo et al.
EXPERIMENTAL AND MOLECULAR MEDICINE (2009)
Lenalidomide (Revlimid®) administration at symptom onset is neuroprotective in a mouse model of amyotrophic lateral sclerosis
Arie Neymotin et al.
EXPERIMENTAL NEUROLOGY (2009)
Light Therapy and Supplementary Riboflavin in the SOD1 Transgenic Mouse Model of Familial Amyotrophic Lateral Sclerosis (FALS)
Helina Moges et al.
LASERS IN SURGERY AND MEDICINE (2009)
LONG-TERM DIETARY ADMINISTRATION OF VALPROIC ACID DOES NOT AFFECT, WHILE RETINOIC ACID DECREASES, THE LIFESPAN OF G93A MICE, A MODEL FOR AMYOTROPHIC LATERAL SCLEROSIS
Cristophe Crochemore et al.
MUSCLE & NERVE (2009)
Survival motor neuron deficiency enhances progression in an amyotrophic lateral sclerosis mouse model
Bradley J. Turner et al.
NEUROBIOLOGY OF DISEASE (2009)
Decline in Daily Running Distance Presages Disease Onset in a Mouse Model of ALS
Daniel A. Bruestle et al.
NEUROMOLECULAR MEDICINE (2009)
Thrombopoietin is ineffective in a mouse model of motor neuron disease
Andrew Caraganis et al.
AMYOTROPHIC LATERAL SCLEROSIS (2008)
Granulocyte-colony stimulating factor improves outcome in a mouse model of amyotrophic lateral sclerosis
Claudia Pitzer et al.
BRAIN (2008)
Ammonium tetrathiomolybdate delays onset, prolongs survival, and slows progression of disease in a mouse model for amyotrophic lateral sclerosis
Eiichi Tokuda et al.
EXPERIMENTAL NEUROLOGY (2008)
Treatment with edaravone, initiated at symptom onset, slows motor decline and decreases SOD1 deposition in ALS mice
Hidefumi Ito et al.
EXPERIMENTAL NEUROLOGY (2008)
Late stage treatment with arimoclomol delays disease progression and prevents protein aggregation in the SOD1G93A mouse model of ALS
Bernadett Kalmar et al.
JOURNAL OF NEUROCHEMISTRY (2008)
Therapeutic benefits of intrathecal protein therapy in a mouse model of amyotrophic lateral sclerosis
Yasuyuki Ohta et al.
JOURNAL OF NEUROSCIENCE RESEARCH (2008)
Familial amyotrophic lateral sclerosis with Gly93Ser mutation in Cu/Zn superoxide dismutase: A clinical and neuropathological study
Megumi Suzuki et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2008)
Effects of estrogen on lifespan and motor functions in female hSOD1 G93A transgenic mice
Chan-Il Choi et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2008)
Human mesenchymal stem cell transplantation extends survival, improves motor performance and decreases neuroinflammation in mouse model of amyotrophic lateral sclerosis
A. Vercelli et al.
NEUROBIOLOGY OF DISEASE (2008)
Folic acid protects motor neurons against the increased homocysteine, inflammation and apoptosis in SOD1(G93A) transgenic mice
Xiaojie Zhang et al.
NEUROPHARMACOLOGY (2008)
被撤回的出版物: INTRANASAL DELIVERY OF INSULIN AND A NITRIC OXIDE SYNTHASE INHIBITOR IN AN EXPERIMENTAL MODEL OF AMYOTROPHIC LATERAL SCLEROSIS (Retracted article. See vol. 275, pg. 549, 2014)
J. A. Martinez et al.
NEUROSCIENCE (2008)
Mitochondrial alterations in dorsal root ganglion cells in sporadic amyotrophic lateral sclerosis
Shoichi Sasaki et al.
ACTA NEUROPATHOLOGICA (2007)
Oral administration of memantine prolongs survival in a transgenic mouse model of amyotrophic lateral sclerosis
In-Soo Joo et al.
JOURNAL OF CLINICAL NEUROLOGY (2007)
Exogenous delivery of heat shock protein 70 increases lifespan in a mouse model of amyotrophic lateral sclerosis
David J. Gifondorwa et al.
JOURNAL OF NEUROSCIENCE (2007)
Antioxidant strategies based on tomato-enriched food or pyruvate do not affect disease onset and survival in an animal model of amyotrophic lateral sclerosis
Ennio Esposito et al.
BRAIN RESEARCH (2007)
The lipophilic metal chelators DP-109 and DP-460 are neuroprotective in a transgenic mouse model of amyotrophic lateral sclerosis
Susanne Petri et al.
JOURNAL OF NEUROCHEMISTRY (2007)
Limited effects of glatiramer acetate in the high-copy number hSOD1-G93A mouse model of ALS
Hans-Joerg Habisch et al.
EXPERIMENTAL NEUROLOGY (2007)
Inhibition of glycogen synthase kinase-3 suppresses the onset of symptoms and disease progression of G93A-SOD1 mouse model of ALS
Seong-Ho Koh et al.
EXPERIMENTAL NEUROLOGY (2007)
Neural stem cells LewisX+CXCR4+modify disease progression in an amyotrophic lateral sclerosis model
Stefania Corti et al.
BRAIN (2007)
Recombinant human erythropoietin suppresses symptom onset and progression of G93A-SOD1 mouse model of ALS by preventing motor neuron death and inflammation
Seong-Ho Koh et al.
EUROPEAN JOURNAL OF NEUROSCIENCE (2007)
The CB2 cannabinoid agonist AM-1241 prolongs survival in a transgenic mouse model of amyotrophic lateral sclerosis when initiated at symptom onset
Jennifer L. Shoemaker et al.
JOURNAL OF NEUROCHEMISTRY (2007)
Therapeutic immunization with a glatiramer acetate derivative does not alter survival in G93A and G37R SOD1 mouse models of familial ALS
Christine Haenggeli et al.
NEUROBIOLOGY OF DISEASE (2007)
Pyruvate slows disease progression in a G93A SOD1 mutant transgenic mouse model
Jong-Ha Park et al.
NEUROSCIENCE LETTERS (2007)
IL-23 is critical in the induction but not in the effector phase of experimental autoimmune encephalomyelitis
Paresh Thakker et al.
JOURNAL OF IMMUNOLOGY (2007)
Loss of Fas ligand-function improves survival in G93A-transgenic ALS mice
Susanne Petri et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2006)
Transient caloric restriction in early adulthood hastens disease endpoint in male, but not female, Cu/Zn-sod mutant G93A mice
Mazien J. Hamadeh et al.
MUSCLE & NERVE (2006)
Reduced oxidative damage in ALS by high-dose enteral melatonin treatment
Jochen H. Weishaupt et al.
JOURNAL OF PINEAL RESEARCH (2006)
Neuroprotective effects of (-)-epigallocatechin-3-gallate in a transgenic mouse model of amyotrophic lateral sclerosis
Zhihao Xu et al.
NEUROCHEMICAL RESEARCH (2006)
Myostatin inhibition slows muscle atrophy in rodent models of amyotrophic lateral sclerosis
Erika L. F. Holzbaur et al.
NEUROBIOLOGY OF DISEASE (2006)
AM1241, a cannabinoid CB2 receptor selective compound, delays disease progression in a mouse model of amyotrophic lateral sclerosis
Kathline Kim et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2006)
Colivelin prolongs survival of an ALS model mouse
T Chiba et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2006)
Therapeutic effects of clenbuterol in a murine model of amyotrophic lateral sclerosis
YD Teng et al.
NEUROSCIENCE LETTERS (2006)
A ketogenic diet as a potential novel therapeutic intervention in amyotrophic lateral sclerosis
Zhong Zhao et al.
BMC NEUROSCIENCE (2006)
Additive neuroprotective effects of a histone deacetylase inhibitor and a catalytic antioxidant in a transgenic mouse model of amyotrophic lateral sclerosis
S Petri et al.
NEUROBIOLOGY OF DISEASE (2006)
The effect of epigallocatechin gallate on suppressing disease progression of ALS model mice
SH Koh et al.
NEUROSCIENCE LETTERS (2006)
Benefit of tianeptine and morphine in a transgenic model of familial amyotrophic lateral sclerosis
M Chritin et al.
AMYOTROPHIC LATERAL SCLEROSIS (2006)
L-Carnitine suppresses the onset of neuromuscular degeneration and increases the life span of mice with familial amyotrophic lateral sclerosis
Y Kira et al.
BRAIN RESEARCH (2006)
Statistical analysis of data from studies on experimental autoimmune encephalomyelitis
KK Fleming et al.
JOURNAL OF NEUROIMMUNOLOGY (2005)
Memantine prolongs survival in an amyotrophic lateral sclerosis mouse model
RG Wang et al.
EUROPEAN JOURNAL OF NEUROSCIENCE (2005)
Manganese porphyrin given at symptom onset markedly extends survival of ALS mice
JP Crow et al.
ANNALS OF NEUROLOGY (2005)
The Wlds gene modestly prolongs survival in the SOD1G93A
LR Fischer et al.
NEUROBIOLOGY OF DISEASE (2005)
Effects of intraperitoneal injection of Rofecoxib in a mouse model of ALS
MF Azari et al.
EUROPEAN JOURNAL OF NEUROLOGY (2005)
Protection by dietary zinc in ALS mutant G93A SOD transgenic mice
IP Ermilova et al.
NEUROSCIENCE LETTERS (2005)
Peroxisome proliferator-activated receptor-gamma agonist extends survival in transgenic mouse model of amyotrophic lateral sclerosis
M Kiaei et al.
EXPERIMENTAL NEUROLOGY (2005)
Caloric restriction transiently improves motor performance but hastens clinical onset of disease in the Cu/Zn-superoxide dismutase mutant G93A mouse
MJ Hamadeh et al.
MUSCLE & NERVE (2005)
Treatment with arimoclomol, a coinducer of heat shock proteins, delays disease progression in ALS mice
D Kieran et al.
NATURE MEDICINE (2004)
Ovariectomy and 17β-estradiol modulate disease progression of a mouse model of ALS
GJ Groeneveld et al.
BRAIN RESEARCH (2004)
Rasagiline alone and in combination with riluzole prolongs survival in an ALS mouse model
S Waibel et al.
JOURNAL OF NEUROLOGY (2004)
Antisense peptide nucleic acid targeting GluR3 delays disease onset and progression in the SOD1 G93A mouse model of familial ALS
A Rembach et al.
JOURNAL OF NEUROSCIENCE RESEARCH (2004)
Benefit of valproic acid in suppressing disease progression of ALS model mice
F Sugai et al.
EUROPEAN JOURNAL OF NEUROSCIENCE (2004)
Extensive exercise is not harmful in amyotrophic lateral sclerosis
D Liebetanz et al.
EUROPEAN JOURNAL OF NEUROSCIENCE (2004)
Effect of p75 neurotrophin receptor antagonist on disease progression in transgenic amyotrophic lateral sclerosis mice
BJ Turner et al.
JOURNAL OF NEUROSCIENCE RESEARCH (2004)
The arachidonic acid 5-lipoxygenase inhibitor nordihydroguaiaretic acid inhibits tumor necrosis factor α activation of microglia and extends survival of G93A-SOD1 transgenic mice
M West et al.
JOURNAL OF NEUROCHEMISTRY (2004)
VEGF delivery with retrogradely transported lentivector prolongs survival in a mouse ALS model
M Azzouz et al.
NATURE (2004)
Chemotherapy delays progression of motor neuron disease in the SOD1 G93A transgenic mouse
KM Bruce et al.
CHEMOTHERAPY (2004)
Effects of high-intensity endurance exercise training in the G93A mouse model of amyotrophic lateral sclerosis
DJ Mahoney et al.
MUSCLE & NERVE (2004)
Magnesium supplementation does not delay disease onset or increase survival in a mouse model of familial ALS
R Pamphlett et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2003)
Zinc amplifies mSOD1-mediated toxicity in a transgenic mouse model of amyotrophic lateral sclerosis
GJ Groeneveld et al.
NEUROSCIENCE LETTERS (2003)
Opposing effects of low and high-dose clozapine on survival of transgenic amyotrophic lateral sclerosis mice
BJ Turner et al.
JOURNAL OF NEUROSCIENCE RESEARCH (2003)
Skeletal muscle properties in a transgenic mouse model for amyotrophic lateral sclerosis: effects of creatine treatment
W Derave et al.
NEUROBIOLOGY OF DISEASE (2003)
The AMPA receptor antagonist NBQX prolongs survival in a transgenic mouse model of amyotrophic lateral sclerosis
P Van Damme et al.
NEUROSCIENCE LETTERS (2003)
Regular exercise is beneficial to a mouse model of amyotrophic lateral sclerosis
IG Kirkinezos et al.
ANNALS OF NEUROLOGY (2003)
Iron porphyrin treatment extends survival in a transgenic animal model of amyotrophic lateral sclerosis
AS Wu et al.
JOURNAL OF NEUROCHEMISTRY (2003)
The efficacy of trientine or ascorbate alone compared to that of the combined treatment with these two agents in familial amyotrophic lateral sclerosis model mice
S Nagano et al.
EXPERIMENTAL NEUROLOGY (2003)
Sexual differences in onset of disease and response to exercise in a transgenic model of ALS
JH Veldink et al.
NEUROMUSCULAR DISORDERS (2003)
Creatine supplementation and riluzole treatment provide similar beneficial effects in copper, zinc superoxide dismutase (G93A) transgenic mice
RJ Snow et al.
NEUROSCIENCE (2003)
Therapeutic efficacy of EGb761 (Gingko biloba extract) in a transgenic mouse model of amyotrophic lateral sclerosis
RJ Ferrante et al.
JOURNAL OF MOLECULAR NEUROSCIENCE (2001)
Effects of an inhibitor of poly(ADP-ribose) polymerase, desmethylselegiline, trientine, and lipoic acid in transgenic ALS mice
OA Andreassen et al.
EXPERIMENTAL NEUROLOGY (2001)
Increases in cortical glutamate concentrations in transgenic amyotrophic lateral sclerosis mice are attenuated by creatine supplementation
OA Andreassen et al.
JOURNAL OF NEUROCHEMISTRY (2001)
Beneficial effect of ginseng root in SOD-1 (G93A) transgenic mice
F Jiang et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2000)
N-acetyl-L-cysteine improves survival and preserves motor performance in an animal model of familial amyotrophic lateral sclerosis
OA Andreassen et al.
NEUROREPORT (2000)
Human umbilical cord blood effect on sod mice (amyotrophic lateral sclerosis)
N Ende et al.
LIFE SCIENCES (2000)